Navigation Links
Femara: The Wonder Drug to Prevent Relapse of Breast Cancer.

The U.S. Food and Drug Administration (FDA) have approved the drug Femara (letrozole) as drug for the treatment of patients suffering from breast cancer among post menopausal women//.

Various studies have been done before the approval of the drug. The result of these studies was published in the December 29 issue of New England Journal of Medicine.

It said that the Novartis drug Femara was very efficient in controlling the recurrence of breast cancer among post menopausal women.

This drug has to be given in the initial therapy after surgery instead of Tamoxifen. This drug is of great importance to both the patients and the clinicians.

The drug is an aromatase inhibitor and prevents/inhibits the production of estrogen hormone. This hormone is the main culprit in inducing post menopausal breast cancers.

This drug is a boon and very useful to all these women suffering from breast cancers which have spread to the lymph nodes and also for women who are done with their chemotherapy.

The main point to be clearly understood by both the patients and clinicians is that the drug has to be prescribed only to postmenopausal women. The reason being that the drug is only effective in these women. If taken by other women will result in fetal damage.

The company has already clearly outlined its side effects which are night sweats, weight gain, joint pain and hot flashes.

This drug is here to stay and help in the treatment of post menopausal breast cancers and advanced breast cancers.


'"/>




Page: 1

Related medicine news :

1. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
2. Wonder drug - could end in disaster
3. Have You Ever Wondered How We Perceive Different Sounds?
4. Soy Not Such A Wonder For Health?
5. Have You Ever Wondered Why Male And Female Voices Differ?
6. Herceptin Not A ‘Wonder’ Drug, Says The Lanct
7. Wonder drug Dasatinib gives hopes to leukemia patients
8. Braces Work Wonders In Setting Crooked Teeth Right
9. Daughter Turns Saviour: Ailing Mother Provided Wonder Drug Herceptin, To Fight Cancer
10. Save Budhia - The Indian Wonder Kid
11. Wonder Drug For Weight Loss Launched In UK
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... (CDC), rising prescription opioid overdose deaths now claim the lives of 62 Americans ... civil case filings against drug manufacturers, distributors, pharmacies and prescribers by more than ...
(Date:4/24/2017)... ... , ... Rod Burkett, CEO of Gardant Management Solutions, was recently featured in ... the forefront of Gardant since it was founded in 1999. His drive and inquisitive ... more than 40 new senior living communities. With his leadership, Gardant has grown to ...
(Date:4/24/2017)... ... 24, 2017 , ... Come to PAINWeekEnd (PWE) Tampa on May 20 and ... educational and exciting 2-day program. , An attendee at a recent PAINWeekEnd said, ... patients” about the course entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant Behavior, ...
(Date:4/24/2017)... NY (PRWEB) , ... April 24, 2017 , ... ... 72 countries clearly shows that over the last decade, student well-being has seriously ... all the boxes of formal education, join the Islamic State to turn the ...
(Date:4/24/2017)... ... ... “The Saint with Trin, and Omega Station”: a triple feature offering nonstop ... published author, Chris Jackson. Chris Jackson grew up in Abilene, Texas. He ... District teaching English. He is heavily involved in the youth group of his local ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... that it will be participating in the Deutsche Bank ... Hotel in Boston, Massachusetts on ... 11:20 a.m. Eastern Time. A live webcast ... Investor Relations website at http://investor.zimmerbiomet.com .  The webcast ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
Breaking Medicine Technology: